Skip to content

Cold Plasma for Dental Restoration and Caries Prevention

Development of a Miniature Plasma Brush for Dental Clinical Applications

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01529606
Enrollment
102
Registered
2012-02-09
Start date
2012-09-30
Completion date
2014-06-30
Last updated
2020-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries, Dental Restoration

Keywords

dental restoration, dental caries, tooth cavity

Brief summary

The main objective of this entire research project is to develop a miniature atmospheric cold plasma brush (m-ACPB) for dental clinical applications. The objective of the clinical trial portion of the study is to compare the longevity and durability of dental composite restorations created using the plasma brush, to that of the standard care in dentistry for treating dental cavities, and effects on caries prevention.

Detailed description

The study will be a randomized controlled trial (RCT) and be approved by the institute review board of the University of Tennessee Health Science Center. The study subjects will be composed of young adults 18-35 years old in order to control effects of age on caries. Also the subjects must be Caucasian or Africa American. Young adult patients will be recruited from the UTHSC dental clinics.The baseline visit include a dental exam by one of the investigators, standard preventive dental care (e.g cleaning, application of fluoride varnish), anthropometric measurements, oral health interview survey. 100 patients who meet all inclusion and exclusion criteria will be recruited after they sign an informed consent form. These patients will be randomly assigned to 1 of 2 study groups. Randomization assignment will be stratified by age and number of teeth with caries. Two study groups will be: 1.) plasma treatment group and 2) standard treatment group. For patients in standard treatment group, they will receive composite resin restoration for all decayed teeth and standard preventive treatment (cleaning and fluoride varnish application) at baseline. For patients in plasma treatment group, they will receive plasma treatment after cavity preparation, composite resin restoration, standard preventive treatment followed by plasma treatment for non-carious teeth. Standard preventive treatment and plasma treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction. Only one composite commercially available will be used during the study.

Interventions

OTHERComposite restoration and tooth cleaning

Standard preventive treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction.

plasma treatment after preparation and for caries prevention

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
Nanova, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* subject must be Caucasian or Africa American, 18-35 years old, have written, completed, informed consent forms; * be generally healthy; * be able to participate in the study; * have no diagnosed periodontitis and pericoronitis; * have no active mucosal diseases such as aphthous ulcers and herpetic stomatitis. They must also agree to follow study instructions. The patients must meet the following specific entry criteria: * 1-5 untreated caries and at least one class II caries.

Exclusion criteria

* each subject must have no diagnosed diabetes mellitus or any other endocrine diseases; * no diagnosed cardiovascular diseases; * no diagnosed immune-compromised diseases, such as HIV and AIDS; * no other serious systemic diseases, such as cancer; * no antibiotic therapy in the past 6 months; * no use of non-steroidal anti-inflammatory drugs (NSAIDS) in the past 3 months; and * no reported use of illicit drugs.

Design outcomes

Primary

MeasureTime frameDescription
Number of Decayed, Missing and Filling Teeth (DMFT)12 monthsNumber of decayed, missing and filling teeth (DMFT) during 12 months
Decayed and Filling Surfaces12 monthsNumber of decayed and filling surfaces
Restoration Failure Rate12 monthsComposite restoration evaluation for fracture or loss of filling partially or completely, with or without recurrent caries.

Countries

United States

Participant flow

Recruitment details

Two more patients were recruited because patients received recruitment information and requested participation in the study.

Participants by arm

ArmCount
Standard Care
Fifty five patients were recruited into standard treatment group and they will receive composite resin restoration for all decayed teeth and standard preventive treatment (cleaning and fluoride varnish application) at baseline. Composite restoration and tooth cleaning: Standard preventive treatment will be repeated on semi-annual (6-month) recall visits. All composite restorations will be placed according to the manufacturer's instruction.
55
Plasma Treatment
Forty seven patients were recruited into plasma treatment group and they will receive plasma treatment after cavity preparation, composite resin restoration, standard preventive treatment followed by plasma treatment for non-carious teeth. Plasma treatment: plasma treatment after preparation and for caries prevention
47
Total102

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up2118

Baseline characteristics

CharacteristicStandard CarePlasma TreatmentTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
55 Participants47 Participants102 Participants
Age, Continuous27.9 years
STANDARD_DEVIATION 4.4
27.7 years
STANDARD_DEVIATION 4.6
27.8 years
STANDARD_DEVIATION 4.6
Education level
4 year college
8 Participants12 Participants20 Participants
Education level
Graduate or professional school
19 Participants16 Participants35 Participants
Education level
High school or below
10 Participants8 Participants18 Participants
Education level
Some college
18 Participants11 Participants29 Participants
Health Insurance
No
13 Participants17 Participants30 Participants
Health Insurance
Yes
42 Participants30 Participants72 Participants
Income level
<$20,000
23 Participants22 Participants45 Participants
Income level
$20,000-$39,999
21 Participants19 Participants40 Participants
Income level
$40,000-$59,999
2 Participants5 Participants7 Participants
Income level
$60,000 or more
9 Participants1 Participants10 Participants
Number of decayed and filling surfaces (DMFS)8.27 tooth surface
STANDARD_DEVIATION 8.28
6.89 tooth surface
STANDARD_DEVIATION 7.5
7.58 tooth surface
STANDARD_DEVIATION 7.76
Number of decayed, missing and filling teeth6.09 tooth
STANDARD_DEVIATION 4.22
5.00 tooth
STANDARD_DEVIATION 4.55
5.54 tooth
STANDARD_DEVIATION 4.38
Number of decayed surfaces (DS)2.06 tooth surface
STANDARD_DEVIATION 6.57
0.66 tooth surface
STANDARD_DEVIATION 1.73
1.57 tooth surface
STANDARD_DEVIATION 3.48
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
39 Participants27 Participants66 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
16 Participants20 Participants36 Participants
Region of Enrollment
United States
55 participants47 participants102 participants
Sex: Female, Male
Female
35 Participants32 Participants67 Participants
Sex: Female, Male
Male
20 Participants15 Participants35 Participants
Tooth brushing
>=3 times per day
8 Participants5 Participants13 Participants
Tooth brushing
Once per day
13 Participants10 Participants23 Participants
Tooth brushing
<one time per day
3 Participants0 Participants3 Participants
Tooth brushing
Twice per day
31 Participants32 Participants63 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 550 / 47
other
Total, other adverse events
0 / 550 / 47
serious
Total, serious adverse events
0 / 550 / 47

Outcome results

Primary

Decayed and Filling Surfaces

Number of decayed and filling surfaces

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Standard CareDecayed and Filling Surfaces9.03 tooth surfaceStandard Deviation 8.14
Plasma TreatmentDecayed and Filling Surfaces7.72 tooth surfaceStandard Deviation 8.16
Primary

Number of Decayed, Missing and Filling Teeth (DMFT)

Number of decayed, missing and filling teeth (DMFT) during 12 months

Time frame: 12 months

Population: 34 participants in standard care group and 29 in plasma group

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of Decayed, Missing and Filling Teeth (DMFT)6.29 teethStandard Deviation 4.07
Plasma TreatmentNumber of Decayed, Missing and Filling Teeth (DMFT)5.14 teethStandard Deviation 4.7
Primary

Restoration Failure Rate

Composite restoration evaluation for fracture or loss of filling partially or completely, with or without recurrent caries.

Time frame: 12 months

Population: After 12 months, in standard care group, we had 27 participants remaining and lost 28 participants; in plasma treatment group, we had 21 participants remaining and lost 26 participants. Units of analysis for composite restoration failure is number of composite restorations in each group. A participant may have more than one composite restoration.

ArmMeasureValue (NUMBER)
Standard CareRestoration Failure Rate2 composite fillings
Plasma TreatmentRestoration Failure Rate0 composite fillings

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026